Company Profile

US High Intensity Focused Ultrasound

Treats primary and recurrent prostate cancer using HIFU (high intensity focused ultrasound), a minimally invasive outpatient procedure which potentially improves patients quality of life. US HIFU manufactures the Sonablate 500, manages and funds two FDA clinical trials and is working to increase access to the technology in locations outside the U.S. where it is has been approved.

Industry
Health
Location
Charlotte, North Carolina
Leadership
Steve Puckett, Jr.
Year Founded
2004
Company Size
51-200 employees
Inc. 5000 Rankings
No. 3623 (2011), No. 597 (2009)
Data as of Publication on Aug. 11, 2020